J.P. Morgan analyst David Adlington maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research Report) today and set ...
The firm’s 50 day moving average price is $23.46 and its 200-day moving average price is $21.51. Fresenius Medical Care has a one year low of $17.93 and a one year high of $25.25.
Alaska Air, Heidrick & Struggles, USANA Health Sciences, General Motors and Fresenius Medical Care have been highlighted in this Value Investor article. Truist raised the firm’s price target on ...
DelveInsight's Artificial Kidney Market Insights report provides the current and forecast market analysis, individual leading ...
Aurora™ is the automated system that streamlines plasma collection, producing virtually cell-free plasma and providing an improved experience for both operators and donors. The system separates ...
News Medical on MSN1d
Children with ARFID at higher risk for long-term health issuesChildren with avoidant restrictive food intake disorder (ARFID) have an elevated risk of developing psychiatric and physical conditions, a new study from Karolinska Institutet published in JAMA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback